DGCRF
9342-8530 Québec Inc.
Save
43
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Medical - Specialties
Industry
9342-8530 Québec Inc., a life sciences company, develops and commercializes products relating to the diagnosis of cancer in Canada. It focuses on molecular diagnostic tests for the detection and management of cancer. The company offers PCA3 test for the diagnosis of prostate cancer; and Guanylyl Cyclase C (GCC) marker and Previstage GCC colorectal cancer staging test for colorectal cancer patients, as well as PCP, a multi marker prostate cancer test.
Similar securities
Based on sector and market capitalization
Report issue